Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Cooper

Concepts (64)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Nephritis
7
2024
52
2.510
Why?
Cyclophosphamide
5
2024
218
1.800
Why?
Immunosuppressive Agents
6
2024
666
1.500
Why?
Mycophenolic Acid
2
2018
81
0.750
Why?
Rheumatology
4
2022
89
0.700
Why?
Lupus Erythematosus, Systemic
3
2023
221
0.540
Why?
Glucocorticoids
2
2022
552
0.500
Why?
Guideline Adherence
1
2018
497
0.470
Why?
Kidney
4
2024
1207
0.400
Why?
Lupus Vasculitis, Central Nervous System
1
2024
7
0.240
Why?
Neurofilament Proteins
1
2024
34
0.230
Why?
Glial Fibrillary Acidic Protein
1
2024
79
0.230
Why?
Arthritis, Juvenile
1
2022
42
0.210
Why?
Nephrology
1
2022
48
0.200
Why?
Adolescent
8
2024
17922
0.200
Why?
Remission Induction
2
2022
240
0.200
Why?
Microscopic Polyangiitis
1
2021
12
0.200
Why?
Granulomatosis with Polyangiitis
1
2021
41
0.190
Why?
Glomerulonephritis
1
2021
45
0.190
Why?
Rituximab
1
2021
149
0.190
Why?
Skin Diseases
1
2022
124
0.180
Why?
Vasculitis
1
2021
71
0.180
Why?
Child
11
2024
18503
0.180
Why?
Consensus
2
2022
537
0.180
Why?
Immunologic Factors
1
2021
220
0.170
Why?
Cognitive Dysfunction
1
2023
279
0.170
Why?
Autoimmune Diseases
1
2021
395
0.160
Why?
Anti-Asthmatic Agents
1
2021
350
0.140
Why?
Acute Kidney Injury
1
2022
646
0.130
Why?
Feasibility Studies
1
2018
748
0.130
Why?
Biomarkers
1
2024
3471
0.120
Why?
Pilot Projects
1
2018
1384
0.110
Why?
Cohort Studies
2
2022
4949
0.110
Why?
Humans
13
2024
115741
0.110
Why?
Female
7
2024
60018
0.100
Why?
Registries
1
2018
1770
0.090
Why?
Practice Patterns, Physicians'
1
2017
1180
0.080
Why?
Treatment Outcome
2
2021
9162
0.080
Why?
Asthma
1
2021
2066
0.080
Why?
Prospective Studies
1
2018
6276
0.070
Why?
Male
6
2024
56050
0.070
Why?
Neuroglia
1
2024
150
0.060
Why?
T-Lymphocytes, Helper-Inducer
1
2023
129
0.050
Why?
Atrophy
1
2022
152
0.050
Why?
Adult
4
2024
30789
0.050
Why?
T-Lymphocyte Subsets
1
2023
383
0.050
Why?
Granuloma
1
2021
85
0.050
Why?
Fibrosis
1
2022
457
0.040
Why?
Renal Dialysis
1
2022
369
0.040
Why?
Eosinophils
1
2021
282
0.040
Why?
Bone Density
1
2022
432
0.040
Why?
B-Lymphocytes
1
2023
773
0.040
Why?
Rheumatologists
1
2017
12
0.040
Why?
Nephrologists
1
2017
12
0.040
Why?
Case-Control Studies
1
2024
3037
0.040
Why?
Retrospective Studies
2
2024
12633
0.030
Why?
Neurons
1
2024
1298
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2021
667
0.030
Why?
Pediatricians
1
2017
125
0.030
Why?
Health Care Surveys
1
2017
538
0.030
Why?
Models, Biological
1
2021
1646
0.030
Why?
Middle Aged
2
2024
27069
0.030
Why?
Young Adult
1
2024
10518
0.020
Why?
United States
1
2024
12304
0.020
Why?
Cooper's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)